52531675,,62048811,21435609,,26107480,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531676,,62048811,21435610,,26107482,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531677,,62048811,21435611,,26107483,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531678,,62048811,21435612,,26107485,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531679,,62048811,21435613,,26107487,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531680,,62048811,21435614,,26107489,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531681,,62048811,21435615,,26107491,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531682,,62048811,21435616,,26107492,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531683,,62048811,21435617,,26107494,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531685,,62048811,21435618,,26107496,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531686,,62048811,21435619,,26107498,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531687,,62048811,21435620,,26107500,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531688,,62048811,21435621,,26107501,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531689,,62048811,21435622,,26107503,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531690,,62048811,21435623,,26107505,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531691,,62048811,21435624,,26107506,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531692,,62048811,21435625,,26107508,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531693,,62048811,21435626,,26107509,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531694,,62048811,21435627,,26107510,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531695,,62048811,21435628,,26107511,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531696,,62048811,21435629,,26107513,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531697,,62048811,21435630,,26107515,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531698,,62048811,21435631,,26107517,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531699,,62048811,21435632,,26107518,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531700,,62048811,21435633,,26107520,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531701,,62048811,21435634,,26107522,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531702,,62048811,21435635,,26107524,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531703,,62048811,21435636,,26107526,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531704,,62048811,21435637,,26107528,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531705,,62048811,21435638,,26107529,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531706,,62048811,21435639,,26107531,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531707,,62048811,21435640,,26107534,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531708,,62048811,21435641,,26107535,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531709,,62048811,21435642,,26107537,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531710,,62048811,21435643,,26107539,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531711,,62048811,21435644,,26107541,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531712,,62048811,21435645,,26107543,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531713,,62048811,21435646,,26107545,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531715,,62048811,21435647,,26107548,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531716,,62048811,21435648,,26107550,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531717,,62048811,21435649,,26107551,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531718,,62048811,21435650,,26107553,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531719,,62048811,21435651,,26107555,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531720,,62048811,21435652,,26107557,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531721,,62048811,21435653,,26107559,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531722,,62048811,21435654,,26107561,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531723,,62048811,21435655,,26107564,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531724,,62048811,21435656,,26107566,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531725,,62048811,21435657,,26107568,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531726,,62048811,21435658,,26107570,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531727,,62048811,21435659,,26107572,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531728,,62048811,21435660,,26107575,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531729,,62048811,21435661,,26107577,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531730,,62048811,21435662,,26107579,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531731,,62048811,21435663,,26107581,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531732,,62048811,21435664,,26107583,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531733,,62048811,21435665,,26107586,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531734,,62048811,21435666,,26107588,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531735,,62048811,21435667,,26107590,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531736,,62048811,21435668,,26107592,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531737,,62048811,21435669,,26107594,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531738,,62048811,21435670,,26107597,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531739,,62048811,21435671,,26107599,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531740,,62048811,21435672,,26107601,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531741,,62048811,21435673,,26107602,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531742,,62048811,21435674,,26107604,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531743,,62048811,21435675,,26107606,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531745,,62048811,21435676,,26107609,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531746,,62048811,21435677,,26107611,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531747,,62048811,21435678,,26107613,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531748,,62048811,21435679,,26107615,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531749,,62048811,21435680,,26107617,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531750,,62048811,21435681,,26107619,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531751,,62048811,21435682,,26107621,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531752,,62048811,21435683,,26107623,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531753,,62048811,21435684,,26107625,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531754,,62048811,21435685,,26107627,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531755,,62048811,21435686,,26107629,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531756,,62048811,21435687,,26107631,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531757,,62048811,21435688,,26107634,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531758,,62048811,21435689,,26107636,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531759,,62048811,21435567,,25291205,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531760,,62048811,21435690,,26107638,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531761,,62048811,21435691,,26107640,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531762,,62048811,21435692,,26107642,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531763,,62048811,21435693,,26107644,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531764,,62048811,21435694,,26107646,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531765,,62048811,21435695,,26107648,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531766,,62048811,21435696,,26107650,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531767,,62048811,21435697,,26107653,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531768,,62048811,21435698,,26107655,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531769,,62048811,21435699,,26107657,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531770,,62048811,21435700,,26107659,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531771,,62048811,21435701,,26107661,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531772,,62048811,21435702,,26107663,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531773,,62048811,21435703,,26107665,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531774,,62048811,21435704,,26107667,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531775,,62048811,21435705,,26107669,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531776,,62048811,21435706,,26107671,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531777,,62048811,21435707,,26107673,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531778,,62048811,21435708,,26107675,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531779,,62048811,21435709,,26107678,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531780,,62048811,21435710,,26107680,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531782,,62048811,21435711,,26107682,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531783,,62048811,21435712,,26107685,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531784,,62048811,21435713,,26107687,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531785,,62048811,21435714,,26107689,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531786,,62048811,21435715,,26107691,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531787,,62048811,21435716,,26107693,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531788,,62048811,21435717,,26107695,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531789,,62048811,21435718,,26107697,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531790,,62048811,21435719,,26107699,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531791,,62048811,21435720,,26107702,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531792,,62048811,21435721,,26107704,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531793,,62048811,21435722,,26107706,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531794,,62048811,21435723,,26107708,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531795,,62048811,21435724,,26107710,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531796,,62048811,21435725,,26107712,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531797,,62048811,21435726,,26107714,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531798,,62048811,21435727,,26107716,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531799,,62048811,21435728,,26107718,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531800,,62048811,21435729,,26107720,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531801,,62048811,21435730,,26107722,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531802,,62048811,21435731,,26107724,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531803,,62048811,21435732,,26107726,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531804,,62048811,21435733,,26107728,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531805,,62048811,21435734,,26107730,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531806,,62048811,21435735,,26107732,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531807,,62048811,21435736,,26107734,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531808,,62048811,21435737,,26107736,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531809,,62048811,21435738,,26107738,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531810,,62048811,21435739,,26107740,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531812,,62048811,21435740,,26107743,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531813,,62048811,21435741,,26107745,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531814,,62048811,21435742,,26107747,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531815,,62048811,21435743,,26107749,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531817,,62048811,21435744,,26107752,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531818,,62048811,21435745,,26107754,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531819,,62048811,21435746,,26107756,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531820,,62048811,21435747,,26107758,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531821,,62048811,21435748,,26107760,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531822,,62048811,21435749,,26107762,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531823,,62048811,21435750,,26107764,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531824,,62048811,21435751,,26107766,,,,,,,,,7168882,IC50,,6089738,,,In Vitro (Efficacy),,,,"Inhibitory concentration of the compound against calcium mobilization in CHO cells expressing Cynomolgus macaque Bradykinin receptor B1 upon incubation in Krebs-Ringer HEPES buffer, pH 7.4 at 37 degree C for 1 h using fluorescent dye Fluo4-AM",,1806883,CHO cell line,,,,Cercopithecidae,3844701,,Bradykinin receptor B1 [Cercopithecidae],Cercopithecidae,Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae]:Wild,Bradykinin receptor B1 [Cercopithecidae],,,Cercopithecidae,,,,<=,5,,µM,5.3,result normalized in M; pAur = -log(value),,,,2018/11/16,Bradykinin receptor B1 [Cercopithecidae],1,2020/03/17,
52531825,,379551,21435770,MAIN,7243251,Ikr blocker,,Single,0.00100000 mg/min/kg,,,,,7168885,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,-1,3,%,,,,,,2018/11/16,,,2018/11/22,
52531826,,379551,21435771,MAIN,7243251,Ikr blocker,,Single,0.0300000 mg/min/kg,,,,,7168885,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,18,5,%,,,,,,2018/11/16,,,2018/11/22,
52531827,,379551,21435769,MAIN,7243251,Ikr blocker,,Single,0.000100000 mg/min/kg,,,,,7168885,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,-7,8,%,,,,,,2018/11/16,,,2018/11/22,
52531828,,379551,21435770,MAIN,7243251,Ikr blocker,,Single,0.00100000 mg/min/kg,,,,,7168886,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,3,4,%,,,,,,2018/11/16,,,2018/11/22,
52531829,,379551,21435769,MAIN,7243251,Ikr blocker,,Single,0.000100000 mg/min/kg,,,,,7168886,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,-1,5,%,,,,,,2018/11/16,,,2018/11/22,
52531830,,379551,21435771,MAIN,7243251,Ikr blocker,,Single,0.0300000 mg/min/kg,,,,,7168886,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,22,5,%,,,,,,2018/11/16,,,2018/11/22,
52531831,,379551,21435770,MAIN,7243251,Ikr blocker,,Single,0.00100000 mg/min/kg,,,,,7168887,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,-1,1,%,,,,,,2018/11/16,,,2018/11/22,
52531832,,379551,21435769,MAIN,7243251,Ikr blocker,,Single,0.000100000 mg/min/kg,,,,,7168887,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,1,1,%,,,,,,2018/11/16,,,2018/11/22,
52531833,,379551,21435771,MAIN,7243251,Ikr blocker,,Single,0.0300000 mg/min/kg,,,,,7168887,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,11,3,%,,,,,,2018/11/16,,,2018/11/22,
52531834,,379551,21435770,MAIN,7243251,Ikr blocker,,Single,0.00100000 mg/min/kg,,,,,7168888,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,1,1,%,,,,,,2018/11/16,,,2018/11/22,
52531835,,379551,21435769,MAIN,7243251,Ikr blocker,,Single,0.000100000 mg/min/kg,,,,,7168888,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,0,2,%,,,,,,2018/11/16,,,2018/11/22,
52531836,,379551,21435771,MAIN,7243251,Ikr blocker,,Single,0.0300000 mg/min/kg,,,,,7168888,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,23,5,%,,,,,,2018/11/16,,,2018/11/22,
52531837,,379551,21435769,MAIN,7243251,Ikr blocker,,Single,0.000100000 mg/min/kg,,,,,7168889,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,-2,1,%,,,,,,2018/11/16,,,2018/11/22,
52531838,,379551,21435770,MAIN,7243251,Ikr blocker,,Single,0.00100000 mg/min/kg,,,,,7168889,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,0,1,%,,,,,,2018/11/16,,,2018/11/22,
52531839,,379551,21435771,MAIN,7243251,Ikr blocker,,Single,0.0300000 mg/min/kg,,,,,7168889,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,7,2,%,,,,,,2018/11/16,,,2018/11/22,
52531840,,379551,21435769,MAIN,7243251,Ikr blocker,,Single,0.000100000 mg/min/kg,,,,,7168890,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,0,2,%,,,,,,2018/11/16,,,2018/11/22,
52531841,,379551,21435770,MAIN,7243251,Ikr blocker,,Single,0.00100000 mg/min/kg,,,,,7168890,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,2,4,%,,,,,,2018/11/16,,,2018/11/22,
52531842,,379551,21435771,MAIN,7243251,Ikr blocker,,Single,0.0300000 mg/min/kg,,,,,7168890,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,4,4,%,,,,,,2018/11/16,,,2018/11/22,
52531843,,379551,21435770,MAIN,7243251,Ikr blocker,,Single,0.00100000 mg/min/kg,,,,,7168891,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,11,1,%,,,,,,2018/11/16,,,2018/11/22,
52531844,,379551,21435769,MAIN,7243251,Ikr blocker,,Single,0.000100000 mg/min/kg,,,,,7168891,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,1,2,%,,,,,,2018/11/16,,,2018/11/22,
52531845,,379551,21435771,MAIN,7243251,Ikr blocker,,Single,0.0300000 mg/min/kg,,,,,7168891,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,21,3,%,,,,,,2018/11/16,,,2018/11/22,
52531846,,379551,21435770,MAIN,7243251,Ikr blocker,,Single,0.00100000 mg/min/kg,,,,,7168892,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,8,1,%,,,,,,2018/11/16,,,2018/11/22,
52531847,,379551,21435769,MAIN,7243251,Ikr blocker,,Single,0.000100000 mg/min/kg,,,,,7168892,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,2,2,%,,,,,,2018/11/16,,,2018/11/22,
52531848,,379551,21435771,MAIN,7243251,Ikr blocker,,Single,0.0300000 mg/min/kg,,,,,7168892,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,9,4,%,,,,,,2018/11/16,,,2018/11/22,
52531849,,379551,21435769,MAIN,7243251,Ikr blocker,,Single,0.000100000 mg/min/kg,,,,,7168893,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,0,1,%,,,,,,2018/11/16,,,2018/11/22,
52531850,,379551,21435771,MAIN,7243251,Ikr blocker,,Single,0.0300000 mg/min/kg,,,,,7168893,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,0,1,%,,,,,,2018/11/16,,,2018/11/22,
52531851,,379551,21435770,MAIN,7243251,Ikr blocker,,Single,0.00100000 mg/min/kg,,,,,7168893,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,3,1,%,,,,,,2018/11/16,,,2018/11/22,
52531852,,379551,21435769,MAIN,7243251,Ikr blocker,,Single,0.000100000 mg/min/kg,,,,,7168894,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,2,1,%,,,,,,2018/11/16,,,2018/11/22,
52531853,,379551,21435770,MAIN,7243251,Ikr blocker,,Single,0.00100000 mg/min/kg,,,,,7168894,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,9,1,%,,,,,,2018/11/16,,,2018/11/22,
52531854,,379551,21435771,MAIN,7243251,Ikr blocker,,Single,0.0300000 mg/min/kg,,,,,7168894,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,13,4,%,,,,,,2018/11/16,,,2018/11/22,
52531855,,379551,21435769,MAIN,7243251,Ikr blocker,,Single,0.000100000 mg/min/kg,,,,,7168895,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,-1,1,%,,,,,,2018/11/16,,,2018/11/22,
52531856,,379551,21435770,MAIN,7243251,Ikr blocker,,Single,0.00100000 mg/min/kg,,,,,7168895,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,-4,3,%,,,,,,2018/11/16,,,2018/11/22,
52531857,,379551,21435771,MAIN,7243251,Ikr blocker,,Single,0.0300000 mg/min/kg,,,,,7168895,percentage,,6089745,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,4,3,%,,,,,,2018/11/16,,,2018/11/22,
52531869,,379551,21435755,MAIN,15688174,cpd1,intravenous administration,Single,0.100000 mg/min/kg,,,,,7168914,concentration (parameter),,6089748,Pharmacokinetic,Pharmacokinetic,Pharmacokinetic,,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,3.4,0.200000,µM,5.47,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52531870,,379551,21435755,MAIN,15688174,cpd1,intravenous administration,Single,0.100000 mg/min/kg,,,,,7168915,concentration (parameter),,6089748,Pharmacokinetic,Pharmacokinetic,Pharmacokinetic,,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,2.8,0.300000,µM,5.55,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52531871,,379551,21435755,MAIN,15688174,cpd1,intravenous administration,Single,0.100000 mg/min/kg,,,,,7168916,percentage,,6089748,Pharmacokinetic,Pharmacokinetic,Pharmacokinetic,,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,5,,%,,,,,,2018/11/16,,,2018/11/22,
52531872,,379551,21435755,MAIN,15688174,cpd1,intravenous administration,Single,0.100000 mg/min/kg,,,,,7168917,percentage,,6089748,Pharmacokinetic,Pharmacokinetic,Pharmacokinetic,,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,10,,%,,,,,,2018/11/16,,,2018/11/22,
52531873,,379551,21435755,MAIN,15688174,cpd1,intravenous administration,Single,0.100000 mg/min/kg,,,,,7168918,percentage,,6089748,Pharmacokinetic,Pharmacokinetic,Pharmacokinetic,,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,16,,%,,,,,,2018/11/16,,,2018/11/22,
52531874,,379551,21435755,MAIN,15688174,cpd1,intravenous administration,Single,0.100000 mg/min/kg,,,,,7168919,percentage,,6089748,Pharmacokinetic,Pharmacokinetic,Pharmacokinetic,,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,5,,%,,,,,,2018/11/16,,,2018/11/22,
52531875,,379551,21435756,MAIN,15688174,cpd1,intravenous administration,Single,0.200000 mg/min/kg,,,,,7168907,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,-17,,%,,,,,,2018/11/16,,,2018/11/22,
52531876,,379551,21435756,MAIN,15688174,cpd1,intravenous administration,Single,0.200000 mg/min/kg,,,,,7168908,concentration (parameter),,6089747,Pharmacokinetic,Pharmacokinetic,Pharmacokinetic,,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,6.3,0.500000,µM,5.2,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52531877,,379551,21435756,MAIN,15688174,cpd1,intravenous administration,Single,0.200000 mg/min/kg,,,,,7168909,concentration (parameter),,6089747,Pharmacokinetic,Pharmacokinetic,Pharmacokinetic,,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,5.5,0.200000,µM,5.26,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52531878,,379551,21435756,MAIN,15688174,cpd1,intravenous administration,Single,0.200000 mg/min/kg,,,,,7168910,percentage,,6089747,Pharmacokinetic,Pharmacokinetic,Pharmacokinetic,,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,14,,%,,,,,,2018/11/16,,,2018/11/22,
52531879,,379551,21435756,MAIN,15688174,cpd1,intravenous administration,Single,0.200000 mg/min/kg,,,,,7168911,percentage,,6089747,Pharmacokinetic,Pharmacokinetic,Pharmacokinetic,,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,24,,%,,,,,,2018/11/16,,,2018/11/22,
52531880,,379551,21435756,MAIN,15688174,cpd1,intravenous administration,Single,0.200000 mg/min/kg,,,,,7168912,percentage,,6089747,Pharmacokinetic,Pharmacokinetic,Pharmacokinetic,,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,11,,%,,,,,,2018/11/16,,,2018/11/22,
52531881,,379551,21435756,MAIN,15688174,cpd1,intravenous administration,Single,0.200000 mg/min/kg,,,,,7168913,percentage,,6089747,Pharmacokinetic,Pharmacokinetic,Pharmacokinetic,,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,12,,%,,,,,,2018/11/16,,,2018/11/22,
52531882,,379551,21435762,MAIN,3570229,amlodipine,intravenous administration,Single,0.0300000 mg/min/kg,,,,,7168920,inhibition rate,,6089749,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,14,,%,,,,,,2018/11/16,,,2018/11/22,
52531883,,379551,21435763,MAIN,3573079,diltiazem,intravenous administration,Single,0.0300000 mg/min/kg,,,,,7168920,inhibition rate,,6089749,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,14,,%,,,,,,2018/11/16,,,2018/11/22,
52531884,,379551,21435763,MAIN,3573079,diltiazem,intravenous administration,Single,0.0300000 mg/min/kg,,,,,7168921,stimulation rate,,6089749,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,9,,%,,,,,,2018/11/16,,,2018/11/22,
52531885,,379551,21435763,MAIN,3573079,diltiazem,intravenous administration,Single,0.0300000 mg/min/kg,,,,,7168922,stimulation rate,,6089749,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,10,,%,,,,,,2018/11/16,,,2018/11/22,
52531886,,379551,21435763,MAIN,3573079,diltiazem,intravenous administration,Single,0.0300000 mg/min/kg,,,,,7168923,percentage,,6089749,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,,,,,12,,%,,,,,,2018/11/16,,,2018/11/22,
52531887,,379551,21435756,MAIN,15688174,cpd1,intravenous administration,Single,0.200000 mg/min/kg,,,,,7168896,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531858,,,,2,2,%,,,,,,2018/11/16,,,2018/11/22,
52531888,,379551,21435754,MAIN,10267089,cpd2,intravenous administration,Single,0.200000 mg/min/kg,Preclinical,,,,7168896,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531858,,,,4,4,%,,,,,,2018/11/16,,,2018/11/22,
52531889,,379551,21435756,MAIN,15688174,cpd1,intravenous administration,Single,0.200000 mg/min/kg,,,,,7168897,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531859,,,,-1,4,%,,,,,,2018/11/16,,,2018/11/22,
52531890,,379551,21435754,MAIN,10267089,cpd2,intravenous administration,Single,0.200000 mg/min/kg,Preclinical,,,,7168897,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531859,,,,8,6,%,,,,,,2018/11/16,,,2018/11/22,
52531891,,379551,21435756,MAIN,15688174,cpd1,intravenous administration,Single,0.200000 mg/min/kg,,,,,7168898,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531860,,,,12,2,%,,,,,,2018/11/16,,,2018/11/22,
52531892,,379551,21435754,MAIN,10267089,cpd2,intravenous administration,Single,0.200000 mg/min/kg,Preclinical,,,,7168898,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531860,,,,27,7,%,,,,,,2018/11/16,,,2018/11/22,
52531893,,379551,21435756,MAIN,15688174,cpd1,intravenous administration,Single,0.200000 mg/min/kg,,,,,7168899,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531861,,,,11,2,%,,,,,,2018/11/16,,,2018/11/22,
52531894,,379551,21435754,MAIN,10267089,cpd2,intravenous administration,Single,0.200000 mg/min/kg,Preclinical,,,,7168899,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531861,,,,33,8,%,,,,,,2018/11/16,,,2018/11/22,
52531895,,379551,21435756,MAIN,15688174,cpd1,intravenous administration,Single,0.200000 mg/min/kg,,,,,7168900,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531862,,,,13,1,%,,,,,,2018/11/16,,,2018/11/22,
52531896,,379551,21435754,MAIN,10267089,cpd2,intravenous administration,Single,0.200000 mg/min/kg,Preclinical,,,,7168900,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531862,,,,22,5,%,,,,,,2018/11/16,,,2018/11/22,
52531897,,379551,21435756,MAIN,15688174,cpd1,intravenous administration,Single,0.200000 mg/min/kg,,,,,7168901,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531863,,,,5,3,%,,,,,,2018/11/16,,,2018/11/22,
52531898,,379551,21435754,MAIN,10267089,cpd2,intravenous administration,Single,0.200000 mg/min/kg,Preclinical,,,,7168901,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531863,,,,26,4,%,,,,,,2018/11/16,,,2018/11/22,
52531899,,379551,21435754,MAIN,10267089,cpd2,intravenous administration,Single,0.200000 mg/min/kg,Preclinical,,,,7168902,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531864,,,,-1,1,%,,,,,,2018/11/16,,,2018/11/22,
52531900,,379551,21435756,MAIN,15688174,cpd1,intravenous administration,Single,0.200000 mg/min/kg,,,,,7168902,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531864,,,,4,2,%,,,,,,2018/11/16,,,2018/11/22,
52531901,,379551,21435754,MAIN,10267089,cpd2,intravenous administration,Single,0.200000 mg/min/kg,Preclinical,,,,7168903,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531865,,,,-3,1,%,,,,,,2018/11/16,,,2018/11/22,
52531902,,379551,21435756,MAIN,15688174,cpd1,intravenous administration,Single,0.200000 mg/min/kg,,,,,7168903,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531865,,,,3,1,%,,,,,,2018/11/16,,,2018/11/22,
52531903,,379551,21435756,MAIN,15688174,cpd1,intravenous administration,Single,0.200000 mg/min/kg,,,,,7168904,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531866,,,,0,0,%,,,,,,2018/11/16,,,2018/11/22,
52531904,,379551,21435754,MAIN,10267089,cpd2,intravenous administration,Single,0.200000 mg/min/kg,Preclinical,,,,7168904,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531866,,,,-3,4,%,,,,,,2018/11/16,,,2018/11/22,
52531905,,379551,21435754,MAIN,10267089,cpd2,intravenous administration,Single,0.200000 mg/min/kg,Preclinical,,,,7168905,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531867,,,,-1,1,%,,,,,,2018/11/16,,,2018/11/22,
52531906,,379551,21435756,MAIN,15688174,cpd1,intravenous administration,Single,0.200000 mg/min/kg,,,,,7168905,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531867,,,,5,1,%,,,,,,2018/11/16,,,2018/11/22,
52531907,,379551,21435754,MAIN,10267089,cpd2,intravenous administration,Single,0.200000 mg/min/kg,Preclinical,,,,7168906,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531868,,,,-8,3,%,,,,,,2018/11/16,,,2018/11/22,
52531908,,379551,21435756,MAIN,15688174,cpd1,intravenous administration,Single,0.200000 mg/min/kg,,,,,7168906,percentage,,6089746,Electrocardiogram : ECG,In vivo Measurement,In Vivo (Animal models),,,,,,1806887,,,,,Sprague Dawley rat,,,,,,,,,,,Sprague Dawley rat,52531868,,,,0,3,%,,,,,,2018/11/16,,,2018/11/22,
52531909,,459784,21435777,MAIN,18528434,(S)-5a,,,,,,,,7168927,Ki (inhibition constant),,6089752,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844714,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],Target,Transfected,,,,,,58.2,18.3000,nM,7.24,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],,2018/11/22,
52531910,,459784,21435792,MAIN,4132986,L-Glu,,,,,,,,7168927,Ki (inhibition constant),,6089752,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844714,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],Target,Transfected,,,,,,169,27,nM,6.77,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],,2018/11/22,
52531911,,459784,21435778,MAIN,18528438,(S)-5b,,,,,,,,7168927,Ki (inhibition constant),,6089752,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844714,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],Target,Transfected,,,,,,102,30,nM,6.99,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],,2018/11/22,
52531912,,459784,21435782,MAIN,3546627,"(R,S)-AMPA",,,,,,,,7168927,Ki (inhibition constant),,6089752,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844714,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],Target,Transfected,,,,,,21.9,4.40000,nM,7.66,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],,2018/11/22,
52531913,,459784,21435797,MAIN,750745,"(R,S)-Willardinine",,,,,,,,7168927,Ki (inhibition constant),,6089752,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844714,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],Target,Transfected,,,,,,410,55,nM,6.39,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],,2018/11/22,
52531914,,459784,21435807,MAIN,9068504,(S)-CPW399,,,,Preclinical,,,,7168927,Ki (inhibition constant),,6089752,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844714,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],Target,Transfected,,,,,,109,5,nM,6.96,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],,2018/11/22,
52531915,,459784,21435776,MAIN,18528433,(S)-8a,,,,,,,,7168927,Ki (inhibition constant),,6089752,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844714,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],Target,Transfected,,,,,,49.9,6.70000,nM,7.3,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],,2018/11/22,
52531916,,459784,21435795,MAIN,4234167,Kainate,,,,Marketed,,,,7168927,Ki (inhibition constant),,6089752,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844714,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],Target,Transfected,,,,,,477,76,nM,6.32,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flop) [rat],,2018/11/22,
52531917,,459784,21435782,MAIN,3546627,"(R,S)-AMPA",,,,,,,,7168929,Ki (inhibition constant),,6089754,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844715,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],Target,Transfected,,,,,,16.8,2.90000,nM,7.77,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],,2018/11/22,
52531918,,459784,21435807,MAIN,9068504,(S)-CPW399,,,,Preclinical,,,,7168929,Ki (inhibition constant),,6089754,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844715,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],Target,Transfected,,,,,,223,24,nM,6.65,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],,2018/11/22,
52531919,,459784,21435776,MAIN,18528433,(S)-8a,,,,,,,,7168929,Ki (inhibition constant),,6089754,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844715,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],Target,Transfected,,,,,,112,26,nM,6.95,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],,2018/11/22,
52531920,,459784,21435777,MAIN,18528434,(S)-5a,,,,,,,,7168929,Ki (inhibition constant),,6089754,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844715,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],Target,Transfected,,,,,,79.7,29.6000,nM,7.1,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],,2018/11/22,
52531921,,459784,21435797,MAIN,750745,"(R,S)-Willardinine",,,,,,,,7168929,Ki (inhibition constant),,6089754,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844715,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],Target,Transfected,,,,,,1200,305,nM,5.92,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],,2018/11/22,
52531922,,459784,21435778,MAIN,18528438,(S)-5b,,,,,,,,7168929,Ki (inhibition constant),,6089754,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844715,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],Target,Transfected,,,,,,126,8,nM,6.9,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],,2018/11/22,
52531923,,459784,21435792,MAIN,4132986,L-Glu,,,,,,,,7168929,Ki (inhibition constant),,6089754,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844715,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],Target,Transfected,,,,,,282,90,nM,6.55,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],,2018/11/22,
52531924,,459784,21435795,MAIN,4234167,Kainate,,,,Marketed,,,,7168929,Ki (inhibition constant),,6089754,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844715,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],Target,Transfected,,,,,,3700,980,nM,5.43,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [rat],,2018/11/22,
52531925,,459784,21435776,MAIN,18528433,(S)-8a,,,,,,,,7168931,Ki (inhibition constant),,6089756,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844716,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],Target,Transfected,,,,,,936,114,nM,6.03,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],,2018/11/22,
52531926,,459784,21435792,MAIN,4132986,L-Glu,,,,,,,,7168931,Ki (inhibition constant),,6089756,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844716,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],Target,Transfected,,,,,,249,12,nM,6.6,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],,2018/11/22,
52531927,,459784,21435782,MAIN,3546627,"(R,S)-AMPA",,,,,,,,7168931,Ki (inhibition constant),,6089756,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844716,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],Target,Transfected,,,,,,20.6,2.60000,nM,7.69,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],,2018/11/22,
52531928,,459784,21435777,MAIN,18528434,(S)-5a,,,,,,,,7168931,Ki (inhibition constant),,6089756,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844716,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],Target,Transfected,,,,,,311,22,nM,6.51,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],,2018/11/22,
52531929,,459784,21435795,MAIN,4234167,Kainate,,,,Marketed,,,,7168931,Ki (inhibition constant),,6089756,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844716,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],Target,Transfected,,,,,,1980,340,nM,5.7,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],,2018/11/22,
52531930,,459784,21435797,MAIN,750745,"(R,S)-Willardinine",,,,,,,,7168931,Ki (inhibition constant),,6089756,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844716,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],Target,Transfected,,,,,,19000,477,nM,4.72,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],,2018/11/22,
52531931,,459784,21435778,MAIN,18528438,(S)-5b,,,,,,,,7168931,Ki (inhibition constant),,6089756,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844716,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],Target,Transfected,,,,,,1500,570,nM,5.82,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],,2018/11/22,
52531932,,459784,21435807,MAIN,9068504,(S)-CPW399,,,,Preclinical,,,,7168931,Ki (inhibition constant),,6089756,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844716,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],Target,Transfected,,,,,,1890,584,nM,5.72,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flop) [rat],,2018/11/22,
52531933,,459784,21435795,MAIN,4234167,Kainate,,,,Marketed,,,,7168933,Ki (inhibition constant),,6089758,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844717,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],Target,Transfected,,,,,,3565,1018,nM,5.45,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],,2018/11/22,
52531934,,459784,21435777,MAIN,18528434,(S)-5a,,,,,,,,7168933,Ki (inhibition constant),,6089758,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844717,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],Target,Transfected,,,,,,288,124,nM,6.54,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],,2018/11/22,
52531935,,459784,21435792,MAIN,4132986,L-Glu,,,,,,,,7168933,Ki (inhibition constant),,6089758,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844717,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],Target,Transfected,,,,,,354,178,nM,6.45,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],,2018/11/22,
52531936,,459784,21435782,MAIN,3546627,"(R,S)-AMPA",,,,,,,,7168933,Ki (inhibition constant),,6089758,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844717,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],Target,Transfected,,,,,,40,19.9000,nM,7.4,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],,2018/11/22,
52531937,,459784,21435797,MAIN,750745,"(R,S)-Willardinine",,,,,,,,7168933,Ki (inhibition constant),,6089758,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844717,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],Target,Transfected,,,,,,14200,3560,nM,4.85,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],,2018/11/22,
52531938,,459784,21435776,MAIN,18528433,(S)-8a,,,,,,,,7168933,Ki (inhibition constant),,6089758,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844717,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],Target,Transfected,,,,,,804,38,nM,6.09,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],,2018/11/22,
52531939,,459784,21435807,MAIN,9068504,(S)-CPW399,,,,Preclinical,,,,7168933,Ki (inhibition constant),,6089758,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844717,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],Target,Transfected,,,,,,2088,495,nM,5.68,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],,2018/11/22,
52531940,,459784,21435778,MAIN,18528438,(S)-5b,,,,,,,,7168933,Ki (inhibition constant),,6089758,Binding,Binding,In Vitro (Efficacy),,,,,,1806891,cells,Membrane,,,,3844717,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],rat,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],Target,Transfected,,,,,,1590,588,nM,5.8,pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [rat],,2018/11/22,
52531941,,459784,21435777,MAIN,18528434,(S)-5a,,,,,,,,7168936,Ki (inhibition constant),,6089761,Binding,Binding,In Vitro (Efficacy),,,,,,1806888,Sf9 cell line,,,,,3844720,,kainate selective glutamate receptor (GluR5-Q) [rat],rat,Wild,kainate selective glutamate receptor (GluR5-Q) [rat]:Wild,kainate selective glutamate receptor (GluR5-Q) [rat]:Wild,kainate selective glutamate receptor (GluR5-Q) [rat],Target,,,,,,,5.2,0.500000,nM,8.28,pAur = -log(value),,,,2018/11/16,kainate selective glutamate receptor (GluR5-Q) [rat],,2018/11/22,
52531942,,459784,21435776,MAIN,18528433,(S)-8a,,,,,,,,7168936,Ki (inhibition constant),,6089761,Binding,Binding,In Vitro (Efficacy),,,,,,1806888,Sf9 cell line,,,,,3844720,,kainate selective glutamate receptor (GluR5-Q) [rat],rat,Wild,kainate selective glutamate receptor (GluR5-Q) [rat]:Wild,kainate selective glutamate receptor (GluR5-Q) [rat]:Wild,kainate selective glutamate receptor (GluR5-Q) [rat],Target,,,,,,,5.3,1.30000,nM,8.28,pAur = -log(value),,,,2018/11/16,kainate selective glutamate receptor (GluR5-Q) [rat],,2018/11/22,
52531943,,459784,21435782,MAIN,3546627,"(R,S)-AMPA",,,,,,,,7168936,Ki (inhibition constant),,6089761,Binding,Binding,In Vitro (Efficacy),,,,,,1806888,Sf9 cell line,,,,,3844720,,kainate selective glutamate receptor (GluR5-Q) [rat],rat,Wild,kainate selective glutamate receptor (GluR5-Q) [rat]:Wild,kainate selective glutamate receptor (GluR5-Q) [rat]:Wild,kainate selective glutamate receptor (GluR5-Q) [rat],Target,,,,,,,1150,114,nM,5.94,pAur = -log(value),,,,2018/11/16,kainate selective glutamate receptor (GluR5-Q) [rat],,2018/11/22,
52531944,,459784,21435797,MAIN,750745,"(R,S)-Willardinine",,,,,,,,7168936,Ki (inhibition constant),,6089761,Binding,Binding,In Vitro (Efficacy),,,,,,1806888,Sf9 cell line,,,,,3844720,,kainate selective glutamate receptor (GluR5-Q) [rat],rat,Wild,kainate selective glutamate receptor (GluR5-Q) [rat]:Wild,kainate selective glutamate receptor (GluR5-Q) [rat]:Wild,kainate selective glutamate receptor (GluR5-Q) [rat],Target,,,,,,,155,22,nM,6.81,pAur = -log(value),,,,2018/11/16,kainate selective glutamate receptor (GluR5-Q) [rat],,2018/11/22,
52531945,,459784,21435795,MAIN,4234167,Kainate,,,,Marketed,,,,7168936,Ki (inhibition constant),,6089761,Binding,Binding,In Vitro (Efficacy),,,,,,1806888,Sf9 cell line,,,,,3844720,,kainate selective glutamate receptor (GluR5-Q) [rat],rat,Wild,kainate selective glutamate receptor (GluR5-Q) [rat]:Wild,kainate selective glutamate receptor (GluR5-Q) [rat]:Wild,kainate selective glutamate receptor (GluR5-Q) [rat],Target,,,,,,,76,27,nM,7.12,pAur = -log(value),,,,2018/11/16,kainate selective glutamate receptor (GluR5-Q) [rat],,2018/11/22,
52531946,,459784,21435778,MAIN,18528438,(S)-5b,,,,,,,,7168936,Ki (inhibition constant),,6089761,Binding,Binding,In Vitro (Efficacy),,,,,,1806888,Sf9 cell line,,,,,3844720,,kainate selective glutamate receptor (GluR5-Q) [rat],rat,Wild,kainate selective glutamate receptor (GluR5-Q) [rat]:Wild,kainate selective glutamate receptor (GluR5-Q) [rat]:Wild,kainate selective glutamate receptor (GluR5-Q) [rat],Target,,,,,,,976,470,nM,6.01,pAur = -log(value),,,,2018/11/16,kainate selective glutamate receptor (GluR5-Q) [rat],,2018/11/22,
52531947,,459784,21435807,MAIN,9068504,(S)-CPW399,,,,Preclinical,,,,7168936,Ki (inhibition constant),,6089761,Binding,Binding,In Vitro (Efficacy),,,,,,1806888,Sf9 cell line,,,,,3844720,,kainate selective glutamate receptor (GluR5-Q) [rat],rat,Wild,kainate selective glutamate receptor (GluR5-Q) [rat]:Wild,kainate selective glutamate receptor (GluR5-Q) [rat]:Wild,kainate selective glutamate receptor (GluR5-Q) [rat],Target,,,,,,,44,6.80000,nM,7.36,pAur = -log(value),,,,2018/11/16,kainate selective glutamate receptor (GluR5-Q) [rat],,2018/11/22,
52531948,,459784,21435792,MAIN,4132986,L-Glu,,,,,,,,7168936,Ki (inhibition constant),,6089761,Binding,Binding,In Vitro (Efficacy),,,,,,1806888,Sf9 cell line,,,,,3844720,,kainate selective glutamate receptor (GluR5-Q) [rat],rat,Wild,kainate selective glutamate receptor (GluR5-Q) [rat]:Wild,kainate selective glutamate receptor (GluR5-Q) [rat]:Wild,kainate selective glutamate receptor (GluR5-Q) [rat],Target,,,,,,,140,7,nM,6.85,pAur = -log(value),,,,2018/11/16,kainate selective glutamate receptor (GluR5-Q) [rat],,2018/11/22,
52531949,,459784,21435797,MAIN,750745,"(R,S)-Willardinine",,,,,,,,7168924,Ki (inhibition constant),,6089750,Binding,Binding,In Vitro (Efficacy),,,,,,1806889,HEK293 cell line,,,,,3844719,,kainate selective glutamate receptor (GluR6-VCR) [rat],rat,Wild,kainate selective glutamate receptor (GluR6-VCR) [rat]:Wild,kainate selective glutamate receptor (GluR6-VCR) [rat]:Wild,kainate selective glutamate receptor (GluR6-VCR) [rat],Target,Transfected,,,,,>,1000000,,nM,1,pAur < 5,,,,2018/11/16,kainate selective glutamate receptor (GluR6-VCR) [rat],,2020/03/17,
52531950,,459784,21435807,MAIN,9068504,(S)-CPW399,,,,Preclinical,,,,7168924,Ki (inhibition constant),,6089750,Binding,Binding,In Vitro (Efficacy),,,,,,1806889,HEK293 cell line,,,,,3844719,,kainate selective glutamate receptor (GluR6-VCR) [rat],rat,Wild,kainate selective glutamate receptor (GluR6-VCR) [rat]:Wild,kainate selective glutamate receptor (GluR6-VCR) [rat]:Wild,kainate selective glutamate receptor (GluR6-VCR) [rat],Target,Transfected,,,,,>,1000000,,nM,1,pAur < 5,,,,2018/11/16,kainate selective glutamate receptor (GluR6-VCR) [rat],,2020/03/17,
52531951,,459784,21435776,MAIN,18528433,(S)-8a,,,,,,,,7168924,Ki (inhibition constant),,6089750,Binding,Binding,In Vitro (Efficacy),,,,,,1806889,HEK293 cell line,,,,,3844719,,kainate selective glutamate receptor (GluR6-VCR) [rat],rat,Wild,kainate selective glutamate receptor (GluR6-VCR) [rat]:Wild,kainate selective glutamate receptor (GluR6-VCR) [rat]:Wild,kainate selective glutamate receptor (GluR6-VCR) [rat],Target,Transfected,,,,,>,1000000,,nM,1,pAur < 5,,,,2018/11/16,kainate selective glutamate receptor (GluR6-VCR) [rat],,2020/03/17,
52531952,,459784,21435777,MAIN,18528434,(S)-5a,,,,,,,,7168924,Ki (inhibition constant),,6089750,Binding,Binding,In Vitro (Efficacy),,,,,,1806889,HEK293 cell line,,,,,3844719,,kainate selective glutamate receptor (GluR6-VCR) [rat],rat,Wild,kainate selective glutamate receptor (GluR6-VCR) [rat]:Wild,kainate selective glutamate receptor (GluR6-VCR) [rat]:Wild,kainate selective glutamate receptor (GluR6-VCR) [rat],Target,Transfected,,,,,>,1000000,,nM,1,pAur < 5,,,,2018/11/16,kainate selective glutamate receptor (GluR6-VCR) [rat],,2020/03/17,
52531953,,459784,21435778,MAIN,18528438,(S)-5b,,,,,,,,7168924,Ki (inhibition constant),,6089750,Binding,Binding,In Vitro (Efficacy),,,,,,1806889,HEK293 cell line,,,,,3844719,,kainate selective glutamate receptor (GluR6-VCR) [rat],rat,Wild,kainate selective glutamate receptor (GluR6-VCR) [rat]:Wild,kainate selective glutamate receptor (GluR6-VCR) [rat]:Wild,kainate selective glutamate receptor (GluR6-VCR) [rat],Target,Transfected,,,,,>,1000000,,nM,1,pAur < 5,,,,2018/11/16,kainate selective glutamate receptor (GluR6-VCR) [rat],,2020/03/17,
52531954,,459784,21435782,MAIN,3546627,"(R,S)-AMPA",,,,,,,,7168924,Ki (inhibition constant),,6089750,Binding,Binding,In Vitro (Efficacy),,,,,,1806889,HEK293 cell line,,,,,3844719,,kainate selective glutamate receptor (GluR6-VCR) [rat],rat,Wild,kainate selective glutamate receptor (GluR6-VCR) [rat]:Wild,kainate selective glutamate receptor (GluR6-VCR) [rat]:Wild,kainate selective glutamate receptor (GluR6-VCR) [rat],Target,Transfected,,,,,>,1000000,,nM,1,pAur < 5,,,,2018/11/16,kainate selective glutamate receptor (GluR6-VCR) [rat],,2020/03/17,
52531955,,459784,21435792,MAIN,4132986,L-Glu,,,,,,,,7168924,Ki (inhibition constant),,6089750,Binding,Binding,In Vitro (Efficacy),,,,,,1806889,HEK293 cell line,,,,,3844719,,kainate selective glutamate receptor (GluR6-VCR) [rat],rat,Wild,kainate selective glutamate receptor (GluR6-VCR) [rat]:Wild,kainate selective glutamate receptor (GluR6-VCR) [rat]:Wild,kainate selective glutamate receptor (GluR6-VCR) [rat],Target,Transfected,,,,,,332,21,nM,6.48,pAur = -log(value),,,,2018/11/16,kainate selective glutamate receptor (GluR6-VCR) [rat],,2018/11/22,
52531956,,459784,21435795,MAIN,4234167,Kainate,,,,Marketed,,,,7168924,Ki (inhibition constant),,6089750,Binding,Binding,In Vitro (Efficacy),,,,,,1806889,HEK293 cell line,,,,,3844719,,kainate selective glutamate receptor (GluR6-VCR) [rat],rat,Wild,kainate selective glutamate receptor (GluR6-VCR) [rat]:Wild,kainate selective glutamate receptor (GluR6-VCR) [rat]:Wild,kainate selective glutamate receptor (GluR6-VCR) [rat],Target,Transfected,,,,,,12.7,3.70000,nM,7.9,pAur = -log(value),,,,2018/11/16,kainate selective glutamate receptor (GluR6-VCR) [rat],,2018/11/22,
52531957,,459784,21435776,MAIN,18528433,(S)-8a,,,,,,,,7168928,EC50,,6089753,Electrophysiology,Electrophysiology,In Vitro (Efficacy),,,Agonist,,,1806892,oocyte,,,,Xenopus laevis,3844709,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],human,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],Target,,Xenopus laevis,,,,,7.2,0.800000,µM,5.14,result normalized in M; pAur = -log(value),,,6,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],,2020/03/17,
52531958,,459784,21435777,MAIN,18528434,(S)-5a,,,,,,,,7168928,EC50,,6089753,Electrophysiology,Electrophysiology,In Vitro (Efficacy),,,Agonist,,,1806892,oocyte,,,,Xenopus laevis,3844709,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],human,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],Target,,Xenopus laevis,,,,,11.8,1.60000,µM,4.93,result normalized in M; pAur = -log(value),,,8,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],,2020/03/17,
52531959,,459784,21435807,MAIN,9068504,(S)-CPW399,,,,Preclinical,,,,7168928,EC50,,6089753,Electrophysiology,Electrophysiology,In Vitro (Efficacy),,,Agonist,,,1806892,oocyte,,,,Xenopus laevis,3844709,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],human,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],Target,,Xenopus laevis,,,,,24.9,3.60000,µM,4.6,result normalized in M; pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],,2020/03/17,
52531960,,459784,21435777,MAIN,18528434,(S)-5a,,,,,,,,7168930,EC50,,6089755,Electrophysiology,Electrophysiology,In Vitro (Efficacy),,,Agonist,,,1806892,oocyte,,,,Xenopus laevis,3844710,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [human],human,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [human],Target,,Xenopus laevis,,,,,12.6,0.600000,µM,4.9,result normalized in M; pAur = -log(value),,,6,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [human],,2020/03/17,
52531961,,459784,21435776,MAIN,18528433,(S)-8a,,,,,,,,7168930,EC50,,6089755,Electrophysiology,Electrophysiology,In Vitro (Efficacy),,,Agonist,,,1806892,oocyte,,,,Xenopus laevis,3844710,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [human],human,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [human],Target,,Xenopus laevis,,,,,11.8,1.10000,µM,4.93,result normalized in M; pAur = -log(value),,,5,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [human],,2020/03/17,
52531962,,459784,21435807,MAIN,9068504,(S)-CPW399,,,,Preclinical,,,,7168930,EC50,,6089755,Electrophysiology,Electrophysiology,In Vitro (Efficacy),,,Agonist,,,1806892,oocyte,,,,Xenopus laevis,3844710,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [human],human,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [human],Target,,Xenopus laevis,,,,,13.9,1.40000,µM,4.86,result normalized in M; pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR2-Q-flip) [human],,2020/03/17,
52531963,,459784,21435776,MAIN,18528433,(S)-8a,,,,,,,,7168932,EC50,,6089757,Electrophysiology,Electrophysiology,In Vitro (Efficacy),,,Agonist,,,1806892,oocyte,,,,Xenopus laevis,3844711,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flip) [human],human,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flip) [human],Target,,Xenopus laevis,,,,,120,14,µM,3.92,result normalized in M; pAur = -log(value),,,9,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flip) [human],,2020/03/17,
52531964,,459784,21435807,MAIN,9068504,(S)-CPW399,,,,Preclinical,,,,7168932,EC50,,6089757,Electrophysiology,Electrophysiology,In Vitro (Efficacy),,,Agonist,,,1806892,oocyte,,,,Xenopus laevis,3844711,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flip) [human],human,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flip) [human],Target,,Xenopus laevis,,,,,224,20,µM,3.65,result normalized in M; pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flip) [human],,2020/03/17,
52531965,,459784,21435777,MAIN,18528434,(S)-5a,,,,,,,,7168932,EC50,,6089757,Electrophysiology,Electrophysiology,In Vitro (Efficacy),,,Agonist,,,1806892,oocyte,,,,Xenopus laevis,3844711,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flip) [human],human,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flip) [human],Target,,Xenopus laevis,,,,,33.9,3.40000,µM,4.47,result normalized in M; pAur = -log(value),,,8,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR3-flip) [human],,2020/03/17,
52531966,,459784,21435776,MAIN,18528433,(S)-8a,,,,,,,,7168934,EC50,,6089759,Electrophysiology,Electrophysiology,In Vitro (Efficacy),,,Agonist,,,1806892,oocyte,,,,Xenopus laevis,3844712,,Glutamate receptor 4 [human];+alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [human],human,Wild,Glutamate receptor 4 [human]:Wild + alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [human]:Wild,Glutamate receptor 4 [human]:Wild + alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [human]:Wild,Glutamate receptor 4 [human] + alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [human],Target,,Xenopus laevis,,,,,90,15,µM,4.05,result normalized in M; pAur = -log(value),,,14,2018/11/16,Glutamate receptor 4 [human];alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [human],,2020/03/17,
52531967,,459784,21435807,MAIN,9068504,(S)-CPW399,,,,Preclinical,,,,7168934,EC50,,6089759,Electrophysiology,Electrophysiology,In Vitro (Efficacy),,,Agonist,,,1806892,oocyte,,,,Xenopus laevis,3844712,,Glutamate receptor 4 [human];+alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [human],human,Wild,Glutamate receptor 4 [human]:Wild + alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [human]:Wild,Glutamate receptor 4 [human]:Wild + alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [human]:Wild,Glutamate receptor 4 [human] + alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [human],Target,,Xenopus laevis,,,,,34.3,2.10000,µM,4.46,result normalized in M; pAur = -log(value),,,,2018/11/16,Glutamate receptor 4 [human];alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [human],,2020/03/17,
52531968,,459784,21435777,MAIN,18528434,(S)-5a,,,,,,,,7168934,EC50,,6089759,Electrophysiology,Electrophysiology,In Vitro (Efficacy),,,Agonist,,,1806892,oocyte,,,,Xenopus laevis,3844712,,Glutamate receptor 4 [human];+alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [human],human,Wild,Glutamate receptor 4 [human]:Wild + alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [human]:Wild,Glutamate receptor 4 [human]:Wild + alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [human]:Wild,Glutamate receptor 4 [human] + alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [human],Target,,Xenopus laevis,,,,,24.2,2.40000,µM,4.62,result normalized in M; pAur = -log(value),,,10,2018/11/16,Glutamate receptor 4 [human];alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR4-flop) [human],,2020/03/17,
52531969,,459784,21435777,MAIN,18528434,(S)-5a,,,,,,,,7168926,EC50,,6089751,Electrophysiology,Electrophysiology,In Vitro (Efficacy),,,Agonist,,,1806890,CHO-K1 cell line,,,,,3844708,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],human,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],Target,Transfected,,,,,,20.3,,µM,4.69,result normalized in M; pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],,2020/03/17,
52531970,,459784,21435776,MAIN,18528433,(S)-8a,,,,,,,,7168926,EC50,,6089751,Electrophysiology,Electrophysiology,In Vitro (Efficacy),,,Agonist,,,1806890,CHO-K1 cell line,,,,,3844708,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],human,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],Target,Transfected,,,,,,4.35,,µM,5.36,result normalized in M; pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],,2020/03/17,
52531971,,459784,21435777,MAIN,18528434,(S)-5a,,,,,,,,7168925,Emax,,6089751,Electrophysiology,Electrophysiology,In Vitro (Efficacy),,,Agonist,,,1806890,CHO-K1 cell line,,,,,3844708,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],human,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],Target,Transfected,,,,,,17.1,,%,,,,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],,2018/11/22,
52531972,,459784,21435776,MAIN,18528433,(S)-8a,,,,,,,,7168925,Emax,,6089751,Electrophysiology,Electrophysiology,In Vitro (Efficacy),,,Agonist,,,1806890,CHO-K1 cell line,,,,,3844708,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],human,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],Target,Transfected,,,,,,27.5,,%,,,,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],,2018/11/22,
52531973,,459784,21435776,MAIN,18528433,(S)-8a,,,,,,,,7168935,IC50,,6089760,Electrophysiology,Electrophysiology,In Vitro (Efficacy),,,Antagonist,,,1806890,CHO-K1 cell line,,,,,3844718,,kainate selective glutamate receptor (GluR5-Q) [human],human,Wild,kainate selective glutamate receptor (GluR5-Q) [human]:Wild,kainate selective glutamate receptor (GluR5-Q) [human]:Wild,kainate selective glutamate receptor (GluR5-Q) [human],Target,Transfected,,,,,,1.9,,µM,5.72,result normalized in M; pAur = -log(value),,,,2018/11/16,kainate selective glutamate receptor (GluR5-Q) [human],,2020/03/17,
52531974,,459784,21435777,MAIN,18528434,(S)-5a,,,,,,,,7168935,IC50,,6089760,Electrophysiology,Electrophysiology,In Vitro (Efficacy),,,Antagonist,,,1806890,CHO-K1 cell line,,,,,3844718,,kainate selective glutamate receptor (GluR5-Q) [human],human,Wild,kainate selective glutamate receptor (GluR5-Q) [human]:Wild,kainate selective glutamate receptor (GluR5-Q) [human]:Wild,kainate selective glutamate receptor (GluR5-Q) [human],Target,Transfected,,,,,,3.8,,µM,5.42,result normalized in M; pAur = -log(value),,,,2018/11/16,kainate selective glutamate receptor (GluR5-Q) [human],,2020/03/17,
52531975,,459784,21435776,MAIN,18528433,(S)-8a,,,,,,,,7168937,IC50,,6089762,Electrophysiology,Electrophysiology,In Vitro (Efficacy),,,Antagonist,,,1806890,CHO-K1 cell line,,,,,3844713,,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],human,Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human]:Wild,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],Target,Transfected,,,,,,0.37,,µM,6.43,result normalized in M; pAur = -log(value),,,,2018/11/16,alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor (GluR1-flip) [human],,2020/03/17,
52531976,,459784,21435812,MAIN,18528451,,,,,,,,,7168938,qualitative,,6089763,,,In Vitro (Efficacy),,,,L-glutamate-induced current responce at iGluR5(Q)1b receptor; inhibition of,,,,,,,,,,,,,,,,,,,,,L-glutamate-induced current responce at iGluR5(Q)1b receptor inhibition was observed; EC50 is given for 8a; 8a is  partial agonist of receptor; for more details see fig. 1Ab,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531977,,459784,21435811,MAIN,18528450,,,,,,,,,7168939,EC50,,6089764,,,In Vitro (Efficacy),,,,iGluR1i receptor; activation of,,,,,,,,,,,,,,,,,,,,,maximal activation at 300μM concentration of 5a was 17.1 (10μM L-glutamate was considered as 100); EC50 is given for 5a; 5a is  partial agonist of receptor; for more details see fig. 1Aa,,30.3,,µM,4.52,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52531978,,459784,21435812,MAIN,18528451,,,,,,,,,7168939,EC50,,6089764,,,In Vitro (Efficacy),,,,iGluR1i receptor; activation of,,,,,,,,,,,,,,,,,,,,,maximal activation at 300μM concentration of 8a was 27.5 (10μM L-glutamate was considered as 100); EC50 is given for 8a; 8a is  partial agonist of receptor; for more details see fig. 1Aa,,4.35,,µM,5.36,result normalized in M; pAur = -log(value),,,,2018/11/16,,,2020/03/17,
52531979,,381721,21435815,MAIN,18526992,,,,,,,,,7168940,qualitative,,6089792,,,In Vivo (Animal models),,,,acute toxic,,1806893,,,,,mouse,,,,,,,,,,,mouse,,,,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531980,,381721,21435814,MAIN,18526991,,,,,,,,,7168940,qualitative,,6089792,,,In Vivo (Animal models),,,,acute toxic,,1806893,,,,,mouse,,,,,,,,,,,mouse,,,,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531981,,381721,21435813,MAIN,18526990,,,,,,,,,7168940,qualitative,,6089792,,,In Vivo (Animal models),,,,acute toxic,,1806893,,,,,mouse,,,,,,,,,,,mouse,,,,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531982,,381721,21435816,MAIN,18526993,,,,,,,,,7168941,qualitative,,6089789,,,In Vivo (Animal models),,,,IL-5 production; decrease of,,,,,,,,,,,,,,,,,,,,,Title compound significantly decreased IL-5 production by PBMCs.,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531983,,381721,21435816,MAIN,18526993,,,,,,,,,7168942,qualitative,,6089776,,,In Vivo (Animal models),,,,interferon-γ production; effect on,,,,,,,,,,,,,,,,,,,,,,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531984,,381721,21435816,MAIN,18526993,,,,,,,,,7168943,qualitative,,6089769,,,In Vitro (Efficacy),,,,GATA-3 production; suppression of,,1806893,,,,,mouse,,,,,,,,,,,mouse,,,GATA-3 content in the lung of title compound treated mice was reduced as compared with lungs of placebo treated mice.,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531985,,381721,21435816,MAIN,18526993,,,,,,,,,7168944,qualitative,,6089766,,,In Vitro (Efficacy),,,,Ag-induced AHR (airway hyper-responsiveness); suppression of,,,,,,,,,,,,,,,,,,,,,"APTI (airway pressure time index) levels in the daily dose and the half daily does title compound treated groups (~200 cmH2O*sec) were significantly lower compared to placebo-treated group (~500 cmH2O*sec), and were essentially the same as naive mice (~230 cmH2O*sec); figure is given.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531986,,381721,21435816,MAIN,18526993,,,,,,,,,7168945,qualitative,,6089790,,,In Vitro (Efficacy),,,,Ag-induced pulmonary inflammation; reduction of,,,,,,,,,,,,,,,,,,,,,"Both normal and half daily doses of title compound significantly reduced the number of eosinophils and total leukocytes in BALF in dose-dependent manner. BALF total leukocyte, x 10E3: ~35-40 (title compound); ~80 (placebo); ~30 (naive). BALF eosinophils, : ~15-25 (title compound); ~60 (placebo); 0 (naive); figure is given.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531987,,381721,21435814,MAIN,18526991,,,,,,,,,7168946,qualitative,,6089777,,,In Vitro (Efficacy),,,,Ag-specific IgE level; increase of,,,,,,,,,,,,,,,,,,,,,"Title compound increases Ag-specific IgE level: IgE, ng/ml: ~1700 (title compound treated group); ~1600 (sham); 0 (naive); figure is given.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531988,,381721,21435815,MAIN,18526992,,,,,,,,,7168947,qualitative,,6089784,,,In Vitro (Efficacy),,,,Ag-specific IgE level; suppression of,,,,,,,,,,,,,,,,,,,,,"Title compound suppresses Ag-specific IgE level in dose-dependent manner: IgE, ng/ml: ~900-700 (title compound group); ~950 (sham); ~20 (naive); figure is given.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531989,,381721,21435813,MAIN,18526990,,,,,,,,,7168947,qualitative,,6089784,,,In Vitro (Efficacy),,,,Ag-specific IgE level; suppression of,,,,,,,,,,,,,,,,,,,,,"Title compound suppresses Ag-specific IgE level: IgE, ng/ml: ~500-600 (title compound treated group); ~750 (sham); ~20 (naive); figure is given.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531990,,381721,21435816,MAIN,18526993,,,,,,,,,7168948,qualitative,,6089774,,,In Vitro (Efficacy),,,,GATA-3 production; suppression of,,,,,,,,,,,,,,,,,,,,,The GATA-3 content in title compound treated cells was reduced; figures are given.,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531991,,381721,21435816,MAIN,18526993,,,,,,,,,7168949,qualitative,,6089779,,,In Vitro (Efficacy),,,,T cell cytokine mRNA expression in lung; effect on,,,,,,,,,,,,,,,,,,,,,"IL-4, IL-5 and IL-13 mRNA expression in the lungs of title compound treated mice was markedly reduced as compared with placebo-treated mice. IFN-γ mRNA expression in the lungs of title compound treated mice was increased as compared with placebo-treated mice; figure is given.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531992,,381721,21435813,MAIN,18526990,,,,,,,,,7168950,qualitative,,6089780,,,In Vitro (Efficacy),,,,Th1 cytokines; increase of,,,,,,,,,,,,,,,,,,,,,Title compound increases Th1 cytokines in dose-dependent manner: IFN-γ (pg/ml): ~ 1800-2200 (title compound treated group); ~1300 (sham); ~3100 (naive); figure is given.,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531993,,381721,21435814,MAIN,18526991,,,,,,,,,7168950,qualitative,,6089780,,,In Vitro (Efficacy),,,,Th1 cytokines; increase of,,,,,,,,,,,,,,,,,,,,,Title compound increases Th1 cytokines: IFN-γ (pg/ml): ~3200 (title compound treated group); ~2800 (sham); ~3250 (naive); figure is given.,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531994,,381721,21435815,MAIN,18526992,,,,,,,,,7168951,qualitative,,6089770,,,In Vitro (Efficacy),,,,Th1 cytokines; suppression of,,,,,,,,,,,,,,,,,,,,,Title compound suppresses Th1 cytokines in dose-dependent manner: IFN-γ (pg/ml): ~ 175-130 (title compound treated group); ~180 (sham); ~200 (naive); figure is given.,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531995,,381721,21435813,MAIN,18526990,,,,,,,,,7168952,qualitative,,6089798,,,In Vitro (Efficacy),,,,Th2 cytokine by splenocytes; suppression of,,,,,,,,,,,,,,,,,,,,,Title compound suppresses Th2 cytokine by splenocytes in dose-dependent manner: IL-4 (pg/ml): ~ 3500-2000 (title compound treated group); ~3100 (sham); ~100 (naive); figure is given.,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531996,,381721,21435815,MAIN,18526992,,,,,,,,,7168952,qualitative,,6089798,,,In Vitro (Efficacy),,,,Th2 cytokine by splenocytes; suppression of,,,,,,,,,,,,,,,,,,,,,Title compound suppresses Th2 cytokine by splenocytes in dose-dependent manner: IL-4 (pg/ml): ~ 60-20 (title compound treated group); ~ 70 (sham); ~ 10 (naive); IL-5 (pg/ml): ~ 350-230 (title compound treated group); ~ 400 (sham); ~ 10 (naive); figure is given.,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531997,,381721,21435814,MAIN,18526991,,,,,,,,,7168952,qualitative,,6089798,,,In Vitro (Efficacy),,,,Th2 cytokine by splenocytes; suppression of,,,,,,,,,,,,,,,,,,,,,Title compound suppresses Th2 cytokine by splenocytes: IL-4 (pg/ml): ~55 (title compound treated group); ~100 (sham); ~100 (naive); figure is given.,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531998,,381721,21435816,MAIN,18526993,,,,,,,,,7168953,qualitative,,6089787,,,In Vitro (Efficacy),,,,Th2 cytokine secretion by splenocytes; effect on,,,,,,,,,,,,,,,,,,,,,"The title compound treatment markedly reduced IL-4 as well as IL- 5 and IL-13 secretion, but did not reduce IFN-y in cells from the normal daily dose treated group and increased IFN-y in the half daily dose treated group to recall antigen stimulation as compared to that in placebo-treated group. No significant difference in IFN-y levels was observed between title compound treated and placebo-treated groups following Con A mitogen stimulation.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52531999,,381721,21435816,MAIN,18526993,,,,,,,,,7168954,qualitative,,6089793,,,In Vitro (Efficacy),,,,Th2 cytokine synthesis D10 cells; suppression of,,,,,,,,,,,,,,,,,,,,,"Title compound significantly suppressed IL-4, IL-5, and IL-13 production by D10 cells; figure is given.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532000,,381721,21435816,MAIN,18526993,,,,,,,,,7168955,qualitative,,6089781,,,In Vitro (Efficacy),,,,Th2 effector memory cells; suppression of,,,,,,,,,,,,,,,,,,,,,Title compound suppresses Th2 effector memory cells.,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532001,,381721,21435816,MAIN,18526993,,,,,,,,,7168956,qualitative,,6089778,,,In Vitro (Efficacy),,,,Th2 mRNA level; suppression of,,,,,,,,,,,,,,,,,,,,,Title compound suppressed Th2 mRNA levels.,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532002,,381721,21435816,MAIN,18526993,,,,,,,,,7168957,qualitative,,6089767,,,In Vitro (Efficacy),,,,Th2 polarized response; modulate of,,,,,,,,,,,,,,,,,,,,,"Title compound significantly suppressed all major Th2 cytokines, IL-4, IL-5 and IL-13, increased IFN-y production and suppressed IL-10 production; decreased IL- 10 rather than increased IL-10 was associated with reduced AHR and reduced Th2 responses. TGF-P levels were not different between formula treated and untreated OVA stimulated cultures. These results suggest that title compound was able to modulate the polarized Th2 responses by SPCs; figure is given.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532003,,381721,21435815,MAIN,18526992,,,,,,,,,7168958,qualitative,,6089794,,,In Vitro (Efficacy),,,,airway hyper-responsiveness (AHR); suppression of,,,,,,,,,,,,,,,,,,,,,"Title compound suppresses AHR in dose-dependent manner: APTI (airway pressure time index) levels in title compound group was ~ 350-250  cmH2O-sec (~ 850 and ~ 350 cmH2O-sec in sham and naive group, respectively); figure is given.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532004,,381721,21435814,MAIN,18526991,,,,,,,,,7168959,qualitative,,6089795,,,In Vitro (Efficacy),,,,allergic asthma APTI (airway pressure time index); reduction of,,,,,,,,,,,,,,,,,,,,,"Title compound reduces allergic asthma APTI (airway pressure time index): APTI levels in title compound treated group was ~900 cmH2O-sec (~1000 and ~300 cmH2O-sec in sham and naive group, respectively); figure is given.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532005,,381721,21435813,MAIN,18526990,,,,,,,,,7168960,qualitative,,6089768,,,In Vitro (Efficacy),,,,allergic asthma APTI (airway pressure time index); suppression of,,,,,,,,,,,,,,,,,,,,,"Title compound suppresses allergic asthma APTI (airway pressure time index) in dose-dependent manner: APTI levels in title compound treated group was ~300-180 cmH2O-sec (~550 and ~250 cmH2O-sec in sham and naive group, respectively); figure is given.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532006,,381721,21435816,MAIN,18526993,,,,,,,,,7168961,qualitative,,6089772,,,In Vitro (Efficacy),,,,contractile responses of trachea rings to acetylcholine; reduction of,,,,,,,,,,,,,,,,,,,,,Responsiveness to Ach was dramatically and significantly reduced in the presence of the title compound; figure is given.,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532007,,381721,21435815,MAIN,18526992,,,,,,,,,7168962,qualitative,,6089797,,,In Vitro (Efficacy),,,,eosinophilic inflammation; suppression of,,,,,,,,,,,,,,,,,,,,,"Title compound suppresses eosinophilic inflammation: number of eosinophils and total leukocytes in BALF were reduced in dose-depentent manner: BALF total leukocyte, x 10E3: ~100-60 (title compound); ~110 (sham); ~30 (naive). BALF eosinophils, : ~35-10 (title compound); ~45 (sham); 0 (naive); figure is given.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532008,,381721,21435813,MAIN,18526990,,,,,,,,,7168962,qualitative,,6089797,,,In Vitro (Efficacy),,,,eosinophilic inflammation; suppression of,,,,,,,,,,,,,,,,,,,,,"Title compound suppresses eosinophilic inflammation: number of eosinophils in BALF was reduced in dose-depentent manner: BALF eosinophil, : ~50-45 (title compound treated group); ~60 (sham); 0 (naive); figure is given.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532009,,381721,21435814,MAIN,18526991,,,,,,,,,7168962,qualitative,,6089797,,,In Vitro (Efficacy),,,,eosinophilic inflammation; suppression of,,,,,,,,,,,,,,,,,,,,,"Title compound suppresses eosinophilic inflammation: number of eosinophils in BALF was reduced: BALF total eosinophil, x10E3: ~30 (title compound treated group); ~55 (sham); 0 (naive); figure is given.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532010,,381721,21435816,MAIN,18526993,,,,,,,,,7168963,qualitative,,6089788,,,In Vitro (Efficacy),,,,goblet cell hyperplasia; suppression of,,,,,,,,,,,,,,,,,,,,,Title compound has a remarkable suppressive effect on goblet cell hyperplasia as compared with placebo; figure is given.,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532011,,381721,21435813,MAIN,18526990,,,,,,,,,7168964,qualitative,,6089791,,,In Vitro (Efficacy),,,,leukocyte inflammation; suppression of,,,,,,,,,,,,,,,,,,,,,"Title compound suppresses leukocyte inflammation: number of total leukocytes in BALF was reduced in dose-depentent manner: BALF total leukocyte, x 10E3: ~95-50 (title compound treated group); ~90 (sham); 0 (naive); figure is given.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532012,,381721,21435814,MAIN,18526991,,,,,,,,,7168964,qualitative,,6089791,,,In Vitro (Efficacy),,,,leukocyte inflammation; suppression of,,,,,,,,,,,,,,,,,,,,,"Title compound suppresses leukocyte inflammation: number of total leukocytes in BALF was reduced: BALF total leukocyte, x 10E3: ~55 (title compound treated group); ~95 (sham); ~8 (naive); figure is given.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532013,,381721,21435814,MAIN,18526991,,,,,,,,,7168965,qualitative,,6089775,,,In Vitro (Efficacy),,,,liver and kidney function; effect on,,,,,,,,,,,,,,,,,,,,,"BIochemical analysis of liver and kidney functions: BUN (mg/mL): 18 (title compound treated group), 19 (sham), 21 (naive); ALT (mg/mL): 38, 55, 33, respectively.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532014,,381721,21435815,MAIN,18526992,,,,,,,,,7168965,qualitative,,6089775,,,In Vitro (Efficacy),,,,liver and kidney function; effect on,,,,,,,,,,,,,,,,,,,,,"BIochemical analysis of liver and kidney functions: BUN (mg/mL): 18 (title compound treated group), 19 (sham), 21 (naive); ALT (mg/mL): 50, 55, 33, respectively.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532015,,381721,21435813,MAIN,18526990,,,,,,,,,7168965,qualitative,,6089775,,,In Vitro (Efficacy),,,,liver and kidney function; effect on,,,,,,,,,,,,,,,,,,,,,"BIochemical analysis of liver and kidney functions: BUN (mg/mL): 22 (title compound treated group), 19 (sham), 21 (naive); ALT (mg/mL): 83, 55, 33, respectively.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532016,,381721,21435816,MAIN,18526993,,,,,,,,,7168966,qualitative,,6089782,,,In Vitro (Efficacy),,,,lung collagen over production; inhibition of,,,,,,,,,,,,,,,,,,,,,"The collagen contents of the title compound treated groups, even in the half normal daily dose-treated group were significantly lower than in the placebo-treated group (~ 6-7 vs. ~11.5 μg collagen/μg protein) and were not different from the naive control, indicating title compound completely inhibited collagen over production in this model of chronic asthma; figure is given.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532017,,381721,21435816,MAIN,18526993,,,,,,,,,7168967,qualitative,,6089773,,,In Vitro (Efficacy),,,,number of CD4+IL-4 producing cells; reduction of,,,,,,,,,,,,,,,,,,,,,The percent CD4+IL-4 producing cells in the title compound treated group was reduced by 47  as compared with the placebo treated group.,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532018,,381721,21435816,MAIN,18526993,,,,,,,,,7168968,qualitative,,6089783,,,In Vitro (Efficacy),,,,number of CD8+IFN-γ producing cells; increase of,,,,,,,,,,,,,,,,,,,,,The CD8+IFN-y producing cells were increased in the title compound treated group as compared with the placebo-treated group.,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532019,,381721,21435816,MAIN,18526993,,,,,,,,,7168969,qualitative,,6089796,,,In Vitro (Efficacy),,,,number of CD8+IL-4 producing cells; effect on,,,,,,,,,,,,,,,,,,,,,There were very few CD8+IL-4 producing cells in title compound treated grroup.,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532020,,381721,21435816,MAIN,18526993,,,,,,,,,7168970,qualitative,,6089765,,,In Vitro (Efficacy),,,,number of antigen specific CD4+INF-γ producing cells; increase of,,,,,,,,,,,,,,,,,,,,,,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532021,,381721,21435816,MAIN,18526993,,,,,,,,,7168971,qualitative,,6089785,,,In Vitro (Efficacy),,,,number of lung cells; reduction of,,,,,,,,,,,,,,,,,,,,,The number of lung cells in the title compound treated mice was 5.5 fold less than in placebo-treated mice and were not different from naive mice (0. 92X106/per lung).,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532022,,381721,21435816,MAIN,18526993,,,,,,,,,7168972,qualitative,,6089786,,,In Vitro (Efficacy),,,,number of memory CD4+IL-4 producing cells (CD3+CD4+CD44+ IL-4+); reduction of,,,,,,,,,,,,,,,,,,,,,The memory CD4+IL-4 producing cells (CD3+CD4+CD44+IL-4) in title compound treated group were reduced by 44 when compared with the placebo-treated group; figure is given.,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532023,,381721,21435816,MAIN,18526993,,,,,,,,,7168973,qualitative,,6089771,,,In Vitro (Efficacy),,,,serum antigen specific IgE level; reduction of,,,,,,,,,,,,,,,,,,,,,"IgE levels were significantly, although not dramatically reduced in the normal daily dose title compound treated group as compared with the placebo treated group. IgE levels in the half daily dose title compound treated group were also lower than the placebo-treated group, but did not reach statistical significance.",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532024,,7786645,21435817,MAIN,16869049,,,,,,,,,7168974,qualitative,,6089799,,,In Vivo (Animal models),,,,,,,,,,,,,,,,,,,,,,,,,,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532025,,4129387,21435818,MAIN,4130553,,,,,,,,,7168975,qualitative,,6089800,,,In Vivo (Animal models),,,,,,,,,,,,,,,,,,,,,,,,,,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532026,,4129387,21435821,MAIN,4155425,,,,,,,,,7168975,qualitative,,6089800,,,In Vivo (Animal models),,,,,,,,,,,,,,,,,,,,,,,,,,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532027,,4129387,21435819,MAIN,4132093,,,,,,,,,7168975,qualitative,,6089800,,,In Vivo (Animal models),,,,,,,,,,,,,,,,,,,,,,,,,,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532028,,4129387,21435820,MAIN,4143609,,,,,,,,,7168975,qualitative,,6089800,,,In Vivo (Animal models),,,,,,,,,,,,,,,,,,,,,,,,,,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532029,,7786319,21435822,MAIN,3661950,,,,,,,,,7168976,qualitative,,6089801,,,In Vivo (Animal models),,,,,,,,,,,,,,,,,,,,,,,,,,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532030,,374974,21435825,MAIN,18337542,,intraperitoneal administration,,,,,,,7168977,Activity,,6089802,,,In Vivo (Animal models),,,,immunogenic,immunogenic agent,,,,,,,,,,,,,,,,,,,,"mice immunized with title substance elicited strong, specific antibody response to the Streptococcus pneumoniae antigens (ELISA titer of pooled sera was 8000 compared to 100 in group received the alum adjuvant alone); diagram given",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532031,,374974,21435823,MAIN,18337540,,intraperitoneal administration,,,,,,,7168977,Activity,,6089802,,,In Vivo (Animal models),,,,immunogenic,immunogenic agent,,,,,,,,,,,,,,,,,,,,"mice immunized with title substance elicited strong, specific antibody response to the Streptococcus pneumoniae antigens (ELISA titer of pooled sera was 8300 compared to 100 in group received the alum adjuvant alone); diagram given",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532032,,374974,21435824,MAIN,18337541,,intraperitoneal administration,,,,,,,7168977,Activity,,6089802,,,In Vivo (Animal models),,,,immunogenic,immunogenic agent,,,,,,,,,,,,,,,,,,,,"mice immunized with title substance elicited strong, specific antibody response to the Streptococcus pneumoniae antigens (ELISA titer of pooled sera was 8400 compared to 100 in group received the alum adjuvant alone); diagram given",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532033,,374974,21435824,MAIN,18337541,,intraperitoneal administration,,,,,,,7168978,Activity,,6089803,,,In Vivo (Animal models),,,,Streptococcus pneumoniae infection; protection against,,,,,,,,,,,,,,,,,,,,,immunization with title substance significantly increased median survival time compared to group received the alum adjuvant alone; diagram given,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532034,,374974,21435823,MAIN,18337540,,intraperitoneal administration,,,,,,,7168978,Activity,,6089803,,,In Vivo (Animal models),,,,Streptococcus pneumoniae infection; protection against,,,,,,,,,,,,,,,,,,,,,immunization with title substance significantly increased median survival time compared to group received the alum adjuvant alone; diagram given,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532035,,374974,21435825,MAIN,18337542,,intraperitoneal administration,,,,,,,7168978,Activity,,6089803,,,In Vivo (Animal models),,,,Streptococcus pneumoniae infection; protection against,,,,,,,,,,,,,,,,,,,,,immunization with title substance significantly increased median survival time compared to group received the alum adjuvant alone; diagram given,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532036,,380049,21435826,MAIN,8187490,,oral administration,,,,,,,7168979,qualitative,,6089804,,,In Vivo (Animal models),,,,vascular differentiation; induction of,,,,,,,,,,,,,,,,,,,,,"Flk-1 positive cells, i. e. endothelial progenitor cells or endothelial cells are increased in ttitle compound administration group; pulmonary capillary endothelial cells were differentiated from GFP mice-derived bone marrow cells; figure is given",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532037,,380049,21435826,MAIN,8187490,,oral administration,,,,,,,7168979,qualitative,,6089804,,,In Vivo (Animal models),,,,vascular differentiation; induction of,,,,,,,,,,,,,,,,,,,,,"number of circulating Sca-1+/Flk-1+/c-kit+ cells increased in title compound-treated mice, that lung parenchyma could therefore receive more progenitor cells from the bone marrow",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532038,,379191,21435829,MAIN,18526411,,intramuscular administration,,,,,,,7168980,qualitative,,6089809,,,In Vivo (Animal models),,,,angiography score; improvement of,,,,,,,,,,,,,,,,,,,,,"Administration of test compound, in the absence of VEGF expression plasmid, strongly improved angiography score (apr 2-times); figure given",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532039,,379191,21435828,MAIN,18526410,,intramuscular administration,,,,,,,7168980,qualitative,,6089809,,,In Vivo (Animal models),,,,angiography score; improvement of,,,,,,,,,,,,,,,,,,,,,"Administration of test compound, in the absence of VEGF expression plasmid, strongly improved angiography score (apr 2-times); figure given",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532040,,379191,21435829,MAIN,18526411,,intramuscular administration,,,,,,,7168981,qualitative,,6089807,,,In Vivo (Animal models),,,,capillary density; increase of,,,,,,,,,,,,,,,,,,,,,"Administration of test compound, in the absence of VEGF expression plasmid, strongly improved capillary density (apr 1.5-times); figure given",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532041,,379191,21435828,MAIN,18526410,,intramuscular administration,,,,,,,7168981,qualitative,,6089807,,,In Vivo (Animal models),,,,capillary density; increase of,,,,,,,,,,,,,,,,,,,,,"Administration of test compound, in the absence of VEGF expression plasmid, strongly improved capillary density (apr 1.5-times); figure given",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532042,,379191,21435829,MAIN,18526411,,intramuscular administration,,,,,,,7168982,qualitative,,6089805,,,In Vivo (Animal models),,,,lactadherin protein production; induction of,,,,,,,,,,,,,,,,,,,,,In vivo intramuscular electrotransfer of test compound markedly increased lactadherin protein expression in the ischemic muscle; figure given,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532043,,379191,21435828,MAIN,18526410,,intramuscular administration,,,,,,,7168982,qualitative,,6089805,,,In Vivo (Animal models),,,,lactadherin protein production; induction of,,,,,,,,,,,,,,,,,,,,,In vivo intramuscular electrotransfer of test compound markedly increased lactadherin protein expression in the ischemic muscle; figure given,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532044,,379191,21435829,MAIN,18526411,,intramuscular administration,,,,,,,7168983,qualitative,,6089808,,,In Vivo (Animal models),,,,tissue Doppler perfusion score; improvement of,,,,,,,,,,,,,,,,,,,,,"Administration of test compound, in the absence of VEGF expression plasmid, strongly improved tissue Doppler perfusion score(apr 1.5-times); figure given",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532045,,379191,21435828,MAIN,18526410,,intramuscular administration,,,,,,,7168983,qualitative,,6089808,,,In Vivo (Animal models),,,,tissue Doppler perfusion score; improvement of,,,,,,,,,,,,,,,,,,,,,"Administration of test compound, in the absence of VEGF expression plasmid, strongly improved tissue Doppler perfusion score(apr 1.5-times); figure given",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532046,,379191,21435827,MAIN,14154254,,,,,,,,,7168984,qualitative,,6089806,,,In Vitro (Efficacy),,,,Akt phosphorylation; induction of,,,,,,,,,,,,,,,,,,,,,"test compound added to cell culture strongly improved AKT phosphorylation (apr 170); test compound-dependent Akt phosphorilation was inhibited by use of anti-αvβ3 antibody, anti-αvβ5 antibody,  but not by anti-β1 antibody; figure given",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532047,,379191,21435827,MAIN,14154254,,,,,,,,,7168985,qualitative,,6089810,,,In Vitro (Efficacy),,,,cell adhesion; induction of,,,,,,,,,,,,,,,,,,,,,"when coated onto tissue culture wells, test compound allows adhesion of HUVEC; test compound-dependent cell adhesion was inhibited (90) by use of anti-αvβ3 antibody, but not by anti-αvβ5 antibodyrast, anti-β1 antibody; figure given",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532048,,61963583,21435842,,18375665,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532049,,61963583,21435853,,18375676,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532050,,61963583,21435854,,18375677,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532051,,61963583,21435831,,18375654,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532052,,61963583,21435830,,18375653,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532053,,61963583,21435835,,18375658,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532054,,61963583,21435839,,18375662,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532055,,61963583,21435844,,18375667,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532056,,61963583,21435837,,18375660,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532057,,61963583,21435857,,18375680,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532058,,61963583,21435836,,18375659,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532059,,61963583,21435833,,18375656,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532060,,61963583,21435838,,18375661,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532061,,61963583,21435832,,18375655,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532062,,61963583,21435834,,18375657,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532063,,61963583,21435880,,18375705,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532064,,61963583,21435864,,18375688,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532065,,61963583,21435889,,18375715,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532066,,61963583,21435841,,18375664,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532067,,61963583,21435840,,18375663,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532068,,61963583,21435862,,18375686,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532069,,61963583,21435851,,18375674,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532070,,61963583,21435900,,18375726,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532071,,61963583,21435883,,18375708,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532072,,61963583,21435885,,18375710,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532073,,61963583,21435909,,18375736,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532074,,61963583,21435879,,18375704,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532075,,61963583,21435867,,18375691,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532076,,61963583,21435869,,18375693,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532077,,61963583,21435894,,18375720,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532078,,61963583,21435870,,18375695,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532079,,61963583,21435845,,18375668,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532080,,61963583,21435874,,18375699,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532081,,61963583,21435846,,18375669,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532082,,61963583,21435843,,18375666,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532083,,61963583,21435911,,25117392,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532084,,382876,21435917,MAIN,18527166,,,,,,,,,7168987,qualitative,,6089831,,,In Vivo (Animal models),,,,NKG2D receptor; effect on,,,,,,,,,,,,,,,,,,,,,incubation of NKG2D-bearing cells with title compound resulted in modulation and internalization of the receptor.,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532085,,61963583,21435895,,18375721,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532086,,61963583,21435903,,18375730,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532087,,382876,21435917,MAIN,18527166,,,,,,,,,7168988,qualitative,,6089829,,,In Vivo (Animal models),,,,NKG2D to ligands binding; blocking of,,,,,,,,,,,,,,,,,,,,,title compound blocks binding of NKG2D to its ligands,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532088,,61963583,21435888,,18375714,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532089,,382876,21435917,MAIN,18527166,,,,,,,,,7168989,qualitative,,6089823,,,In Vivo (Animal models),,,,NKG2D+ CD8+ T cells; depletion of,,,,,,,,,,,,,,,,,,,,,,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532090,,61963583,21435850,,18375673,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532091,,61963583,21435865,,18375689,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532092,,382876,21435917,MAIN,18527166,,,,,,,,,7168990,qualitative,,6089817,,,In Vivo (Animal models),,,,NKG2D+ NK cells; depletion of,,,,,,,,,,,,,,,,,,,,,,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532093,,382876,21435917,MAIN,18527166,,,,,,,,,7168991,qualitative,,6089835,,,In Vivo (Animal models),,,,autoimmune type I diabetes; prevention of,,,,,,,,,,,,,,,,,,,,,none of the NOD mice treated with title compound developed diabetes at 30 weeks of age; figure given,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532094,,61963583,21435899,,18375725,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532095,,382876,21435917,MAIN,18527166,,,,,,,,,7168992,qualitative,,6089828,,,In Vivo (Animal models),,,,autoimmune type I diabetes; prevention of,,,,,,,,,,,,,,,,,,,,,no diabetes occurred in any of the NOD mice during the 12 weeks of  treatment with title compound; most of the treated mice remained disease-free 7 weeks after halting therapy; figure given,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532096,,61963583,21435897,,18375723,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532097,,382876,21435917,MAIN,18527166,,,,,,,,,7168993,qualitative,,6089837,,,In Vitro (Efficacy),,,,CD8+ T cell CD44 expression; reduction of,,,,,,,,,,,,,,,,,,,,,,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532098,,61963583,21435887,,18375712,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532099,,382876,21435917,MAIN,18527166,,,,,,,,,7168994,qualitative,,6089818,,,In Vitro (Efficacy),,,,CD8+ T cell NKG2D expression; reduction of,,,,,,,,,,,,,,,,,,,,,NKG2D expression was significantly reduced on CD8+ T cells from the pancreas of treated animals; CD8+ T cells expressing NKG2D were relatively infrequent in the PLN of both control and treated mice; figure given,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532100,,61963583,21435905,,18375732,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532101,,382876,21435917,MAIN,18527166,,,,,,,,,7168995,qualitative,,6089839,,,In Vitro (Efficacy),,,,CD8+ T cell in the pancreas; reduction of,,,,,,,,,,,,,,,,,,,,,many fewer CD8+ T cells were present in the healthy pancreas of 16 week-old mice that had been treated for nine weeks with title compound; figure given,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532102,,61963583,21435860,,18375684,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532103,,382876,21435917,MAIN,18527166,,,,,,,,,7168996,qualitative,,6089815,,,In Vitro (Efficacy),,,,CD8+ T cells IFN-γ production; inhibition of,,,,,,,,,,,,,,,,,,,,,"Upon stimulation with PMA and ionomycin in vitro, fewer IFN-γ+ CD8+  T cells were observed in mice undergoing therapy with tittle compound; figure given",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532104,,61963583,21435868,,18375692,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532105,,382876,21435917,MAIN,18527166,,,,,,,,,7168997,qualitative,,6089833,,,In Vitro (Efficacy),,,,NK cells cytotoxicity; inhibition of,,,,,,,,,,,,,,,,,,,,,title compound blocked cytotoxicity of activated NK cells to freshly isolated RAE-1ε transgenic B6 bone marrow cells; figure given,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532106,,382876,21435917,MAIN,18527166,,,,,,,,,7168998,qualitative,,6089821,,,In Vitro (Efficacy),,,,NKG2D+ 8.3 TcR-transgenic CD8+ T cells accumulation in pancreas; decrease of,,,,,,,,,,,,,,,,,,,,,NKG2D was not detected on the cell surface of the transferred CSFE-labeled 8.3 TcR-transgenic CD8+ T cells in the pancreas of NOD mice treated with title compound; figure given,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532107,,61963583,21435863,,18375687,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532108,,61963583,21435848,,18375671,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532109,,382876,21435917,MAIN,18527166,,,,,,,,,7168999,qualitative,,6089827,,,In Vitro (Efficacy),,,,NKG2D+ CD8+ T cells accumulation in pancreas; decrease of,,,,,,,,,,,,,,,,,,,,,title compoumd inhibited the expansion and/or accumulation of NKG2D+  CD8+ T cells in the pancreas; figure given,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532110,,382876,21435917,MAIN,18527166,,,,,,,,,7169000,qualitative,,6089825,,,In Vitro (Efficacy),,,,NRP-V7/H-2Kd  tetramer-positive 8.3 TcR-transgenic CD8+ T cells expansion in pancreas; decrease of,,,,,,,,,,,,,,,,,,,,,Expansion of the endogenous CSFE-unlabeled T cells in the pancreas detected with the NRP-V7/H2Kd  tetramer was also diminished by treatment with title compound; figure given,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532111,,61963583,21435912,,26012486,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532112,,61963583,21435913,,26012487,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532113,,382876,21435917,MAIN,18527166,,,,,,,,,7169001,qualitative,,6089812,,,In Vitro (Efficacy),,,,NRP-V7/H-2Kd  tetramer-positive CD8+ T cells infiltration into pancreas; decrease of,,,,,,,,,,,,,,,,,,,,,infiltration of autoreactive NRP-V7/H-2Kd  tetramer-positive CD8+ T cells into the pancreas was dramatically decreased (apr. 75)  in mice treated with title compound; figure given,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532114,,61963583,21435910,,25112939,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532115,,382876,21435917,MAIN,18527166,,,,,,,,,7169002,qualitative,,6089826,,,In Vitro (Efficacy),,,,NRP-V7/H-2Kd  tetramer-positive CD8+ T cells infiltration into pancreas; decrease of,,,,,,,,,,,,,,,,,,,,,significantly fewer NRP-V7/H-2Kd  tetramer-positive CD8+ T cells infiltrating the pancreas were found in title compoumd-treated mice; figure given,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532116,,61963583,21435873,,18375698,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532117,,382876,21435917,MAIN,18527166,,,,,,,,,7169003,qualitative,,6089822,,,In Vitro (Efficacy),,,,NRP-V7/H-2Kd  tetramer-positive CD8+ T cells infiltration into pancreatic lymph node (PLN); decrease of,,,,,,,,,,,,,,,,,,,,,"The frequency ofNRP-V7/H-2Kd  tetramer-positive CD8+T cells was also decreased in the PLN of treated mice, compared with control mice; figure given",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532118,,61963583,21435893,,18375719,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532119,,382876,21435917,MAIN,18527166,,,,,,,,,7169004,qualitative,,6089836,,,In Vitro (Efficacy),,,,NRP-V7/H-2Kd  tetramer-positive CD8+ T cells infiltration into peripheral blood; decrease of,,,,,,,,,,,,,,,,,,,,,"The frequency ofNRP-V7/H-2Kd  tetramer-positive CD8+T cells was also decreased in the peripheral blood of treated mice, compared with control mice; figure given",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532120,,61963583,21435847,,18375670,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532121,,382876,21435917,MAIN,18527166,,,,,,,,,7169005,qualitative,,6089832,,,In Vitro (Efficacy),,,,NRP-V7/H-2Kd  tetramer-positive CD8+ T cells infiltration into spleen; decrease of,,,,,,,,,,,,,,,,,,,,,"The frequency ofNRP-V7/H-2Kd  tetramer-positive CD8+T cells was also decreased in the spleen of treated mice, compared with control mice; figure given",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532122,,61963583,21435896,,18375722,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532123,,382876,21435917,MAIN,18527166,,,,,,,,,7169006,qualitative,,6089816,,,In Vitro (Efficacy),,,,anti-inflammatoryCD8+ T cell NKG2D expression; reduction of,,,,,,,,,,,,,,,,,,,,,"NKG2D was present on most NRP-V7/H-2Kd tetramer-positive autoreactive CD8+T cells in the control NOD mice, but was not detected on the mice receiving title compound; figure given",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532124,,61963583,21435901,,18375728,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532125,,382876,21435917,MAIN,18527166,,,,,,,,,7169007,qualitative,,6089830,,,In Vitro (Efficacy),,,,autoimmune type I diabetes; prevention of,,,,,,,,,,,,,,,,,,,,,Treatment with a title compound during the pre-diabetic stage completely prevented disease,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532126,,61963583,21435904,,18375731,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532127,,382876,21435917,MAIN,18527166,,,,,,,,,7169008,qualitative,,6089834,,,In Vitro (Efficacy),,,,autoimmune type I diabetes; prevention of,,,,,,,,,,,,,,,,,,,,,none of the title compound-treated mice developed diabetes while undergoing therapy; figure given,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532128,,61963583,21435872,,18375697,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532129,,382876,21435917,MAIN,18527166,,,,,,,,,7169009,qualitative,,6089820,,,In Vitro (Efficacy),,,,autoreactive antigen-specific CD8+T cells expansion; effect on,,,,,,,,,,,,,,,,,,,,,therapy with title compound indicated a profound effect on expansion of the autoreactive antigen-specific CD8+T cells; figure given,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532130,,61963583,21435891,,18375717,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532131,,382876,21435917,MAIN,18527166,,,,,,,,,7169010,qualitative,,6089813,,,In Vitro (Efficacy),,,,bone marrow rejection; prevention of,,,,,,,,,,,,,,,,,,,,,irradiated non-transgenic B6 mice rejected bone marrow cells from RAE-1ε transgenic B6 donors; rejection was prevented in mice treated with the title compound; figure given,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532132,,61963583,21435898,,18375724,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532133,,382876,21435917,MAIN,18527166,,,,,,,,,7169011,qualitative,,6089814,,,In Vitro (Efficacy),,,,bone marrow rejection; prevention of,,,,,,,,,,,,,,,,,,,,,"The RAE-1#  transgenic CB6F1 bone marrow cells, unlike non-transgenic RAE-1ε CB6F1 bone marrow cells were rejected by the syngeneic non-transgenic CB6F1 recipients; rejection was prevented in mice treated with the title compound; figure given",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532134,,61963583,21435849,,18375672,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532135,,382876,21435917,MAIN,18527166,,,,,,,,,7169012,qualitative,,6089819,,,In Vitro (Efficacy),,,,hematopoietic cell reconstitution; increase of,,,,,,,,,,,,,,,,,,,,,"Title compound dramatically increased hematopoietic cell reconstitution of recipient mice (evaluated by incorporation of 125IUdR), comparable to the effects of depleting NK cells; figure given",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532136,,61963583,21435906,,18375733,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532137,,61963583,21435859,,18375683,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532138,,382876,21435917,MAIN,18527166,,,,,,,,,7169013,qualitative,,6089838,,,In Vitro (Efficacy),,,,rejection of B/c bone marrow cells; prevention of,,,,,,,,,,,,,,,,,,,,,"title compound was abile prevent rejection of B/c bone marrow cells (shown by examining the cells repopulating the spleens on day 8 post- transplantation - RAE-1-positive cells predominately co-expressing CD43, Ly-6C/G, and CD11b were detected); figure given",ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532139,,61963583,21435908,,18375735,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532140,,382876,21435916,MAIN,18527165,,,,,,,,,7169014,qualitative,,6089824,,,In Vitro (Efficacy),,,,surface NKG2D internalization; stimulation of,,,,,,,,,,,,,,,,,,,,,title compound is effective at stimulating internalization of surface NKG2D on these human cells; figure given,ND,,,,,,,,,2018/11/16,,,2018/11/22,
52532141,,61963583,21435876,,18375701,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532142,,61963583,21435866,,18375690,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532143,,61963583,21435882,,18375707,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532144,,61963583,21435877,,18375702,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532145,,61963583,21435892,,18375718,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532146,,61963583,21435852,,18375675,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532147,,61963583,21435884,,18375709,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532148,,61963583,21435890,,18375716,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532149,,61963583,21435875,,18375700,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532150,,61963583,21435861,,18375685,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532151,,61963583,21435902,,18375729,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532152,,61963583,21435907,,18375734,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532153,,61963583,21435871,,18375696,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532154,,61963583,21435855,,18375678,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532155,,61963583,21435856,,18375679,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532156,,61963583,21435878,,18375703,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532157,,61963583,21435881,,18375706,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532158,,61963583,21435858,,18375681,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532159,,61963583,21435886,,18375711,,,,,,,PROMEGA PTK BIOTINYL-PEPTIDE,= 0.5 µm,7168986,qualitative,,6089811,,INHIBITORY ACTIVITY,In Vitro (Efficacy),,,,"Inhibitory activity of the compound (dissolved in DMSO) against human recombinant full length wildtype Bruton's Tyrosine Kinase expressed in Sf9 cells infected with Passage 3 virus using 0.5 uM Promega PTK Biotinyl-peptide as substrate upon incubation for 1 hour at RT in 25 mM Tris-HCl buffer, pH 7.5 in presence of 40 uM ATP",,1806894,Sf9 cell line,,,,human,3844721,,Tyrosine-protein kinase BTK [human],human,Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human]:Wild,Tyrosine-protein kinase BTK [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,Tyrosine-protein kinase BTK [human],1,2018/11/22,
52532160,,62031664,21435919,,20522545,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532161,,62031664,21435923,,20522550,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532162,,62031664,21435921,,20522547,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532163,,62031664,21435918,,20522544,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532164,,62031664,21435948,,20522596,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532165,,62031664,21435966,,20522625,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532166,,62031664,21436000,,20522675,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532167,,62031664,21435970,,20522633,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532168,,62031664,21435976,,20522640,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532169,,62031664,21435922,,20522549,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532170,,62031664,21435951,,20522599,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532171,,62031664,21435959,,20522610,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532172,,62031664,21435950,,20522598,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532173,,62031664,21435952,,20522600,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532174,,62031664,21435956,,20522606,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532175,,62031664,21435944,,20522587,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532176,,62031664,21435946,,20522592,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532177,,62031664,21435945,,20522591,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532178,,62031664,21435961,,20522616,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532179,,62031664,21435995,,20522669,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532180,,62031664,21435983,,20522648,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532181,,62031664,21435990,,20522661,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532182,,62031664,21435960,,20522614,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532183,,62031664,21435963,,20522619,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532184,,62031664,21436003,,20522679,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532185,,62031664,21436002,,20522677,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532186,,62031664,21435975,,20522639,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532187,,62031664,21436001,,20522676,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532188,,62031664,21435955,,20522605,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532189,,62031664,21435940,,20522582,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532190,,62031664,21435977,,20522641,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
52532191,,62031664,21435925,,20522557,,,,,,,,,7169015,qualitative,,6089840,,Agonistic activity,In Vitro (Efficacy),,,Agonist,AGONISTIC ACTIVITY OF THE COMPOUND TOWARDS HUMAN ALPHA-2C ADRENERGIC RECEPTOR EXPRESSED IN CHO-K1 CELLS USING [35S]GTPGAMMAS AS RADIOLIGAND IN PRESENCE OF GDP UPON INCUBATION IN ASSAY BUFFER FOR 30 MIN AT RT,,1806896,CHO-K1 cell line,,,,human,3844723,,alpha-2c adrenergic receptor [human],human,Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human]:Wild,alpha-2c adrenergic receptor [human],,,human,,,,Not Published,,,,,,,,,2018/11/16,alpha-2c adrenergic receptor [human],1,2018/11/22,
